Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChenavari Toro Regulatory News (TORO)

Share Price Information for Chenavari Toro (TORO)

Share Price is delayed by 15 minutes
Get Live Data
0.5475    0.00 (0.00%)
Bid:
0.54
Ask:
0.555
Spread: 0.015 (2.778%)
Market Cap: €172.47m
TORO Live PriceLast checked at - London Stock Exchange

Intraday Chenavari Toro Share Chart

Change of Portfolio Manager

7 Dec 2020 17:00

RNS Number : 8254H
Chenavari Toro Income Fund Limited
07 December 2020
 

Chenavari Toro Income Fund Limited (the Company)

Legal Entity Identifier: 549300POOPYI3IQZNS35

 07 December 2020

Change of Portfolio Manager

The Board of directors of the Company and Chenavari Credit Partners LLP ("Chenavari") have today agreed, that with effect from the date of this announcement, Benoit Pellegrini will hand over day to day responsibility for the portfolio management of the Company's investment portfolio within Chenavari to Frederic Couderc, in accordance with the succession plan agreed with the Board.

Whilst he is stepping down from his role as the portfolio manager of the Company's portfolio, it has been agreed that Benoit Pellegrini will continue to assist Frederic Couderc until 30 September 2021, in order to ensure a smooth transition of the portfolio manager role.

The Board believes that the appointment of Frederic Couderc meets the Company's long-term strategic objectives, and the investment strategy and policy of the Company will remain unchanged.

Identified as a Key Man in the Company's prospectus dated 25 April 2015, Frederic Couderc has been with Chenavari since 2009 and has been acting as Co-Chief Investment Officer since 2011. Frederic Couderc led the development of the ABS strategies within Chenavari. In 2009 he launched with Benoit Pellegrini the Toro Capital I fund (Toro I), the predecessor to the Company. He was the architect of the transition from Toro I to a permanent capital listed vehicle through the IPO of the Company in 2015.

 

Signalling further their alignment with the Company's shareholders, Frederic Couderc has bought approximately two thirds of Benoit Pellegrini's shareholding in the Company (representing 8,930,000 shares) at a price of EUR 0.5923 per share, a premium over the closing price of a share as at

4 December 2020 (being EUR 0.56). As part of this transaction, Loic Fery, founder and Co-Chief Investment Officer of Chenavari, has bought 2,679,000 shares from Frederic Couderc (corresponding to 30% of the total shares purchased by Frederic Couderc from Benoit Pellegrini). Following these transactions, Frederic Couderc and Loic Fery are now interested in approximately 7.50% and 7.41% of the issued share capital of the Company respectively versus 5.44% and 6.53% previously. Benoit Pellegrini retains an interest in 4,646,673 shares representing approximately 1.47% of the issued share capital of the Company.

Fred Hervouet, Chairman of the Company, commented:

Frederic Couderc co-founded Toro I in 2009 and contributed actively to the development of the Company, working closely with Benoit Pellegrini through the years. We welcome his appointment as portfolio manager of the Company's investment portfolio and look forward to a renewed focus on the continued reduction in the share price discount to NAV and maximising value for all investors in the Company. We also strongly value the acquisition of shares by Frederic Couderc and Loic Fery at a premium to the current market price. This demonstrates their conviction in the value of the Company, and their commitment to reduce the discount and create strong alignment with the shareholders of the Company. Finally, I would like to thank Benoit Pellegrini for his considerable work with the Company and the Board over the years.

An Investor Call will be organised by the Company in the New Year.

Further information in relation to the Company is available at:

http://www.chenavaritoroincomefund.com 

Enquiries:

Sophie Porter / Guy Goyard

Chenavari Investment Managers

 

Email: tlir@chenavari.com 

 

Telephone: +44 20 7259 3600

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. This announcement has been authorised for release by the Board of Directors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPDZMGZVNDGGZM
Date   Source Headline
29th May 20267:00 amRNSCompany Factsheet Available
27th May 20265:00 pmRNSNet Asset Value(s)
14th May 20265:00 pmRNSScrip Dividend Election
1st May 20267:00 amRNSCompany Factsheet Available
29th Apr 20265:01 pmRNSDividend Declaration
29th Apr 20265:00 pmRNSNet Asset Value(s)
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20265:00 pmRNSCompany Factsheet Available
24th Mar 20265:00 pmRNSNet Asset Value(s)
6th Mar 20265:00 pmRNSShares in Issue
6th Mar 202610:30 amRNSResult of AGM
3rd Mar 20265:00 pmRNSCompany Factsheet Available
25th Feb 20265:00 pmRNSNet Asset Value(s)
13th Feb 20267:00 amRNSScrip Dividend Election
6th Feb 20267:00 amRNSNotice of AGM
29th Jan 20263:58 pmRNSDividend Declaration
29th Jan 20267:01 amRNSCompany Factsheet Available
29th Jan 20267:00 amRNSDividend Declaration
27th Jan 20265:00 pmRNSNet Asset Value(s)
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSCompany Factsheet Available
31st Dec 20257:00 amRNSCompany Factsheet Available
19th Dec 20257:00 amRNSNet Asset Value(s)
18th Dec 20255:00 pmRNSAnnual Report and Audited Financial Statements
18th Dec 20255:00 pmRNSAnnual Report and Audited Financial Statements
5th Dec 20255:00 pmRNSShares in Issue
28th Nov 20257:00 amRNSCompany Factsheet Available
21st Nov 20255:00 pmRNSNet Asset Value(s)
13th Nov 20255:00 pmRNSScrip Dividend Election Price
5th Nov 20255:00 pmRNSShares in Issue
3rd Nov 20255:00 pmRNSQuarterly Investor Webinar
29th Oct 20257:00 amRNSDividend Declaration
22nd Oct 20255:00 pmRNSCompany Factsheet Available
20th Oct 20255:00 pmRNSNet Asset Value(s)
1st Oct 20257:00 amRNSTotal Voting Rights
25th Sep 20255:00 pmRNSCompany Factsheet Available
22nd Sep 20255:00 pmRNSNet Asset Value(s)
19th Sep 20255:00 pmRNSDirector/PDMR Shareholding
5th Sep 20255:00 pmRNSShares in Issue
28th Aug 20257:00 amRNSCompany Factsheet Available
22nd Aug 20255:00 pmRNSNet Asset Value(s)
14th Aug 20255:00 pmRNSScrip Dividend Election Price
25th Jul 20257:01 amRNSQuarterly Investor Webinar
25th Jul 20257:00 amRNSDividend Declaration
23rd Jul 20257:00 amRNSCompany Factsheet Available
18th Jul 20255:00 pmRNSNet Asset Value(s)
1st Jul 20257:00 amRNSTotal Voting Rights
25th Jun 20257:00 amRNSInterim Financial Statements
18th Jun 20255:00 pmRNSCompany Factsheet Available

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.